共 221 条
[1]
Carmina E(1999)Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women J Clin Endocrinol Metab 84 1897-1899
[2]
Lobo RA(2011)Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction Eur J Endocrinol 164 61-68
[3]
Pepene CE(2009)Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population Metab Clin Exp 58 714-721
[4]
Ilie IR(2012)Ethinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome? BMC Endocr Disord 12 9-146
[5]
Marian I(1999)Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 141-169
[6]
Duncea I(1999)Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 165-1023
[7]
Glueck CJ(2002)Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome J Clin Endocrinol Metab 87 1017-2749
[8]
Morrison JA(2004)The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2745-1236
[9]
Goldenberg N(2005)Polycystic ovary syndrome N Engl J Med 352 1223-4592
[10]
Wang P(2013)Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline J Clin Endocrinol Metab 98 4565-511